Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Open in Screener

LAB

Standard BioTools Inc

Oct 23 • 12:05PM ET

1.80

Dollar change -0.04
Percentage change -1.90	%

Healthcare • Medical Devices • USA • NASD

Peers: TMO DHR A ILMN BIO QGEN TECH TWST PACB DNA

| Held by: VTI ARKG IWM VXF IWN SCHA VTWO VHT IWC IWO

Index	RUT	P/E	-	EPS (ttm)	-0.90	Insider Own	3.24%	Shs Outstand	371.15M	Perf Week	-4.50%
Market Cap	669.93M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	349.00%	Shs Float	359.12M	Perf Month	-8.38%
Income	-164.66M	PEG	-	EPS next Q	-0.09	Inst Own	72.52%	Short Float	5.93%	Perf Quarter	-22.86%
Sales	136.30M	P/S	4.92	EPS this Y	56.74%	Inst Trans	4.80%	Short Ratio	10.42	Perf Half Y	-25.41%
Book/sh	1.37	P/B	1.31	EPS next Y	48.36%	ROA	-22.29%	Short Interest	21.29M	Perf Year	-14.45%
Cash/sh	1.06	P/C	1.70	EPS next 5Y	-8.06%	ROE	-59.79%	52W Range	1.21 - 3.04	Perf YTD	-18.33%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.72%	ROI	-30.48%	52W High	-40.63%	Beta	1.57
Dividend TTM	-	Quick Ratio	3.53	Sales past 5Y	-0.06%	Gross Margin	46.67%	52W Low	49.17%	ATR (14)	0.10
Dividend Ex-Date	-	Current Ratio	3.88	EPS Y/Y TTM	15.31%	Oper. Margin	-83.01%	RSI (14)	43.95	Volatility	4.99% 4.89%
Employees	539	Debt/Eq	0.18	Sales Y/Y TTM	29.25%	Profit Margin	-120.81%	Recom	1.00	Target Price	3.17
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	43.31%	Payout	-	Rel Volume	0.50	Prev Close	1.84
Sales Surprise	-22.89%	EPS Surprise	-44.06%	Sales Q/Q	34.48%	Earnings	Oct 30 AMC	Avg Volume	2.04M	Price	1.80
SMA20	-2.63%	SMA50	-6.39%	SMA200	-19.37%	Trades		Volume	433,114	Change	-1.90%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-24	Initiated	TD Cowen	Buy	$3.50
Apr-04-24	Initiated	Jefferies	Buy	$3.25
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight	$4

Oct-21-24 09:03PM	Millennium Management LLC Acquires Shares in Standard BioTools Inc (GuruFocus.com)
Oct-16-24 08:00AM	Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire)
Oct-03-24 04:56AM	Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5? (Insider Monkey)
Sep-24-24 08:00AM	Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan 11K Platform (GlobeNewswire) +5.35%
Sep-18-24 08:00AM	Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH) (GlobeNewswire)
08:00AM	Loading…
Aug-26-24 08:00AM	Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-23-24 06:03PM	Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors (Barrons.com) +9.74%
Aug-06-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-01-24 09:14AM	Q2 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -36.61%
Jul-31-24 09:57PM	LAB Stock Earnings: Standard BioTools Reported Results for Q2 2024 (InvestorPlace)
05:40PM	Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:36PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Standard BioTools Announces Senior Leadership Changes (GlobeNewswire)
04:01PM	Standard BioTools Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-17-24 08:01AM	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire)
04:01PM	Loading…
May-28-24 04:01PM	Standard BioTools Purchases the Carterra LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers (GlobeNewswire)
May-22-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-20-24 08:00AM	Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-13-24 10:45AM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:59PM	LAB Stock Earnings: Standard BioTools Reported Results for Q1 2024 (InvestorPlace) -5.49% +7.59%
04:33PM	Standard BioTools: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 11:27AM	Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction (MT Newswires)
08:01AM	Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth (GlobeNewswire)
08:00AM	Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-08-24 08:00AM	Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging (GlobeNewswire) +5.11%
Apr-03-24 04:01PM	Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research (GlobeNewswire)
Mar-18-24 08:12AM	Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock (GlobeNewswire)
Mar-05-24 08:27AM	Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 06:29AM	Q4 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -5.06%
04:41PM	Loading…
Feb-28-24 04:41PM	Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... (GuruFocus.com)
04:16PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 08:00AM	Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing (GlobeNewswire)
Feb-22-24 04:05PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-14-24 08:30AM	Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Feb-07-24 08:30AM	Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine (GlobeNewswire)
Jan-08-24 08:30AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue (GlobeNewswire) +13.37%
Jan-05-24 08:46AM	Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools (GlobeNewswire)
Jan-04-24 10:23PM	Standard BioTools Stockholders Approve Merger with SomaLogic (GlobeNewswire) -5.39%
09:44PM	SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting (PR Newswire)
Dec-29-23 05:04PM	Glass Lewis Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-28-23 04:16PM	Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools (PR Newswire) +5.45%
Dec-26-23 03:59PM	SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure (PR Newswire) +7.54%
Dec-22-23 06:57PM	ISS Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-21-23 08:00AM	SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools (GlobeNewswire)
Dec-20-23 09:00AM	Skye Fund III Issues Letter Regarding Opposition to SomaLogic's Proposed Merger with Standard BioTools (GlobeNewswire) -8.10%
Dec-17-23 03:37PM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-12-23 04:32PM	SomaLogic Shareholder Madryn Opposes Standard BioTools Merger (Bloomberg)
Dec-11-23 10:37AM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-06-23 11:18AM	Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC) (GlobeNewswire)
Dec-04-23 08:00AM	Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger (GlobeNewswire)
Nov-09-23 05:54AM	Q3 2023 Somalogic Inc Earnings Call (Thomson Reuters StreetEvents) +6.84%
Nov-08-23 12:47PM	Standard BioTools Inc. (NASDAQ:LAB) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:52AM	Q3 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 04:23PM	Standard BioTools: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Standard BioTools Reports Third Quarter and Year-to-Date 2023 Financial Results (GlobeNewswire)
Nov-02-23 08:30AM	Standard BioTools to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-25-23 08:30AM	Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire) -10.50%
Oct-10-23 10:22AM	Moore Kuehn Encourages VERY, PNT, LAB, and LVOX Investors to Contact Law Firm (GlobeNewswire)
Oct-05-23 02:42PM	Moore Kuehn Encourages APRN, FRGI, LAB, and CPRI Investors to Contact Law Firm (PR Newswire)
Oct-04-23 06:49PM	Why SomaLogic Stock Dived by 10% on Wednesday (Motley Fool) -22.22%
08:52AM	Standard BioTools to Combine with SomaLogic in $1 Billion Merger (Bloomberg)
08:00AM	Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools (GlobeNewswire)
Aug-09-23 09:06AM	Q2 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) +7.56%
Aug-08-23 05:36PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Standard BioTools Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:05PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-25-23 04:05PM	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-13-23 07:33AM	Strong week for Standard BioTools (NASDAQ:LAB) shareholders doesn't alleviate pain of five-year loss (Simply Wall St.)
Jun-14-23 07:30AM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-13-23 01:30PM	With 45% ownership, Standard BioTools Inc. (NASDAQ:LAB) has piqued the interest of institutional investors (Simply Wall St.)
May-25-23 04:05PM	Standard BioTools to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-24-23 07:11AM	With Standard BioTools Up 29%, Insider Buyers Count Their Returns \ (Simply Wall St.)
06:05AM	Jeffrey Black Spends US$194k On Standard BioTools Stock \ (Simply Wall St.)
May-18-23 07:30AM	Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System (GlobeNewswire) +12.05%
May-15-23 07:30AM	Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +7.34%
May-10-23 02:47PM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2023 Earnings Call Transcript (Insider Monkey) +12.85%
06:16AM	Q1 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-23 06:11PM	Standard BioTools: Q1 Earnings Snapshot (AP Finance)
04:05PM	Standard BioTools Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-25-23 04:30PM	Standard BioTools Announces Conference Call and Webcast for First Quarter 2023 Financial Results (GlobeNewswire)
Apr-20-23 05:03PM	Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-23 10:42AM	Standard BioTools Inc.'s (NASDAQ:LAB) Low P/S No Reason For Excitement (Simply Wall St.)
Apr-17-23 08:30AM	Standard BioTools introduces the Hyperion XTi Imaging System, breaks barriers to power significant advancement in spatial biology (GlobeNewswire)
Mar-22-23 08:30AM	Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-15-23 08:30AM	Standard BioTools Announces Appointment of Fenel Eloi to Board of Directors (GlobeNewswire)
Mar-14-23 08:30AM	Standard BioTools to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (GlobeNewswire) +11.05%
Mar-01-23 04:05PM	Standard BioTools to Present at 43rd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-21-23 08:30AM	Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-17-23 06:43PM	Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-15-23 06:01PM	How a Peninsula biotech tools company looks to corral 'one-trick ponies' (American City Business Journals)
Feb-14-23 04:05PM	Standard BioTools Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Business Outlook (GlobeNewswire)
Feb-03-23 05:30AM	The past five years for Standard BioTools (NASDAQ:LAB) investors has not been profitable (Simply Wall St.)
Jan-31-23 08:30AM	Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-09-23 08:30AM	Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update (GlobeNewswire) +6.45%
Jan-03-23 08:30AM	Standard BioTools Announces Appointment of Betsy Jensen as Chief Human Resources Officer (GlobeNewswire) +11.11%
Dec-24-22 08:01AM	Standard BioTools Inc. (NASDAQ:LAB) institutional owners may be pleased with recent gains after 64% loss over the past year (Simply Wall St.)
Nov-28-22 08:30AM	Standard BioTools Authorizes up to $20 Million of Share Repurchases (GlobeNewswire) +10.00%
Nov-22-22 09:20AM	Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Taich Adam	Former Officer	Sep 09 '24	Proposed Sale	2.00	45,851	91,725		Sep 09 03:19 PM
Casdin Partners Master Fund, L	Director	Aug 27 '24	Buy	2.19	250,000	546,750	54,025,821	Aug 29 08:30 PM
Casdin Partners Master Fund, L	Director	Aug 23 '24	Buy	2.13	292,100	620,975	53,625,821	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 22 '24	Buy	1.96	307,900	602,807	53,333,721	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 26 '24	Buy	2.15	150,000	322,455	53,775,821	Aug 26 08:10 PM
Casdin Partners Master Fund, L	Director	Aug 21 '24	Buy	1.90	500,000	951,950	53,025,821	Aug 21 08:47 PM
Casdin Partners Master Fund, L	Director	Aug 20 '24	Buy	1.87	500,000	936,700	52,525,821	Aug 21 08:47 PM
Casdin Partners Master Fund, L	Director	Aug 19 '24	Buy	1.85	250,000	463,225	52,025,821	Aug 21 08:47 PM
Black Jeffrey G.	SVP & Chief Financial Officer	Aug 15 '24	Option Exercise	0.00	13,157	0	432,993	Aug 19 05:30 PM
Casdin Partners Master Fund, L	Director	Aug 14 '24	Buy	1.59	1,200,000	1,913,520	51,775,821	Aug 16 07:52 PM
Casdin Partners Master Fund, L	Director	Aug 13 '24	Buy	1.62	550,000	890,560	50,575,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 09 '24	Buy	1.61	525,408	848,481	49,525,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 12 '24	Buy	1.64	500,000	820,600	50,025,821	Aug 13 08:15 PM
Casdin Partners Master Fund, L	Director	Aug 08 '24	Buy	1.64	569,562	932,601	49,000,413	Aug 09 09:34 PM
Casdin Partners Master Fund, L	Director	Aug 07 '24	Buy	1.57	500,000	786,200	48,430,821	Aug 09 09:34 PM
Casdin Partners Master Fund, L	Director	Aug 02 '24	Buy	1.63	1,000,000	1,631,900	47,730,821	Aug 06 09:58 PM
Casdin Partners Master Fund, L	Director	Aug 05 '24	Buy	1.58	200,000	316,780	47,930,821	Aug 06 09:58 PM
Casdin Partners Master Fund, L	Director	May 23 '24	Buy	2.60	100,000	260,000	46,075,821	May 28 08:45 PM
Casdin Partners Master Fund, L	Director	May 21 '24	Buy	2.56	350,000	895,930	45,825,821	May 22 07:53 PM
Casdin Partners Master Fund, L	Director	May 22 '24	Buy	2.58	150,000	387,735	45,975,821	May 22 07:53 PM
Casdin Partners Master Fund, L	Director	May 20 '24	Buy	2.58	100,000	258,130	45,475,821	May 22 07:53 PM
Casdin Partners Master Fund, L	Director	May 15 '24	Buy	2.57	500,000	1,282,550	44,523,749	May 17 08:11 PM
Casdin Partners Master Fund, L	Director	May 16 '24	Buy	2.54	500,000	1,270,950	45,023,749	May 17 08:11 PM
Casdin Partners Master Fund, L	Director	May 17 '24	Buy	2.56	352,072	902,044	45,375,821	May 17 08:11 PM
Black Jeffrey G.	SVP & Chief Financial Officer	May 15 '24	Option Exercise	0.00	52,631	0	138,615	May 16 09:07 PM
Egholm Michael	President & CEO	Apr 04 '24	Option Exercise	0.00	196,512	0	422,030	Apr 05 06:59 PM
Kim Hanjoon Alex	Chief Operating Officer	Apr 04 '24	Option Exercise	0.00	70,183	0	140,366	Apr 05 06:58 PM
Casdin Partners Master Fund, L	Director	Mar 04 '24	Buy	2.57	250,000	642,500	11,496,525	Mar 06 07:20 PM
Casdin Partners Master Fund, L	Director	Mar 05 '24	Buy	2.62	1,403	3,669	11,497,928	Mar 06 07:20 PM

Open in Screener

BLFS

Biolife Solutions Inc

Oct 23 • 12:05PM ET

22.08

Dollar change -0.53
Percentage change -2.34	%

Healthcare • Medical Instruments & Supplies • USA • NASD

BLFS Biolife Solutions Inc daily Stock Chart

Peers: CRSP CYRX NTLA BIO BMRN FATE NARI ASTE ONVO KPTI

| Held by: IJR VTI IWM VXF SPSM IWO IJT VTWO SCHA IJS

Index	RUT	P/E	-	EPS (ttm)	-1.45	Insider Own	2.63%	Shs Outstand	45.17M	Perf Week	-3.78%
Market Cap	1.02B	Forward P/E	-	EPS next Y	-0.26	Insider Trans	-5.91%	Shs Float	44.93M	Perf Month	-10.92%
Income	-64.56M	PEG	-	EPS next Q	-0.08	Inst Own	102.42%	Short Float	7.90%	Perf Quarter	-4.12%
Sales	126.11M	P/S	8.08	EPS this Y	66.84%	Inst Trans	6.36%	Short Ratio	11.25	Perf Half Y	28.46%
Book/sh	6.97	P/B	3.17	EPS next Y	49.21%	ROA	-14.82%	Short Interest	3.55M	Perf Year	126.25%
Cash/sh	0.74	P/C	29.83	EPS next 5Y	10.00%	ROE	-17.78%	52W Range	8.92 - 26.73	Perf YTD	35.89%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.51%	ROI	-18.77%	52W High	-17.39%	Beta	1.87
Dividend TTM	-	Quick Ratio	1.81	Sales past 5Y	57.29%	Gross Margin	35.09%	52W Low	147.55%	ATR (14)	0.96
Dividend Ex-Date	-	Current Ratio	2.86	EPS Y/Y TTM	25.16%	Oper. Margin	-32.62%	RSI (14)	38.68	Volatility	3.47% 3.65%
Employees	414	Debt/Eq	0.11	Sales Y/Y TTM	-22.26%	Profit Margin	-51.19%	Recom	1.00	Target Price	28.90
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-9.45%	Payout	-	Rel Volume	0.62	Prev Close	22.61
Sales Surprise	18.30%	EPS Surprise	-15.69%	Sales Q/Q	-28.30%	Earnings	Aug 08 AMC	Avg Volume	315.69K	Price	22.08
SMA20	-6.24%	SMA50	-9.48%	SMA200	7.23%	Trades		Volume	83,054	Change	-2.34%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-30-24	Initiated	H.C. Wainwright	Buy	$29
Apr-04-24	Initiated	Jefferies	Buy	$22
Jul-11-23	Initiated	Craig Hallum	Buy	$29
Apr-25-22	Upgrade	Oppenheimer	Perform → Outperform	$28
Oct-19-21	Initiated	B. Riley Securities	Buy	$61
Oct-15-21	Resumed	Cowen	Outperform	$64
May-14-21	Downgrade	The Benchmark Company	Buy → Hold
Mar-23-21	Upgrade	The Benchmark Company	Hold → Buy	$54
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$40
Sep-22-20	Downgrade	Oppenheimer	Outperform → Perform
Sep-18-20	Initiated	Cowen	Outperform	$33
Aug-11-20	Downgrade	The Benchmark Company	Buy → Hold
Jul-08-20	Reiterated	Maxim Group	Buy	$18 → $26
Feb-24-20	Initiated	Lake Street	Buy	$25
Feb-19-20	Initiated	The Benchmark Company	Buy	$24
Feb-06-20	Resumed	B. Riley FBR	Buy	$27
Jan-08-20	Initiated	Stephens	Overweight	$23
Nov-21-19	Initiated	Oppenheimer	Outperform	$22
Jul-22-19	Initiated	H.C. Wainwright	Buy	$23
Nov-10-17	Reiterated	Maxim Group	Buy	$7 → $8

Show Previous Ratings

Oct-21-24 09:40AM	Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? (Zacks)
Oct-09-24 05:55PM	BioLife Solutions Inc (BLFS) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -5.13%
Oct-07-24 08:50AM	Here's Why Momentum in BioLife Solutions (BLFS) Should Keep going (Zacks)
Sep-30-24 09:41AM	Disney upgraded, JPMorgan downgraded: Wall Street's top analyst calls (The Fly)
Sep-17-24 09:40AM	Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? (Zacks) -7.89%
02:05AM	Loading…
Aug-19-24 02:05AM	BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q2 (Insider Monkey)
Aug-08-24 09:58PM	BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +11.04%
05:45PM	BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports Second Quarter 2024 Financial Results (PR Newswire)
Aug-06-24 03:56PM	Is BioLife Solutions, Inc. (BLFS) the Best Organ Transplant and Diagnosis Stock to Buy Now? (Insider Monkey)
Jul-25-24 04:03PM	BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 (PR Newswire)
Jul-12-24 08:50AM	What Makes BioLife Solutions (BLFS) a Good Fit for 'Trend Investing' (Zacks)
Jun-18-24 07:00PM	Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com)
May-31-24 11:17AM	BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase (Zacks)
May-29-24 08:04AM	BioLife Solutions Introduces the CellSeal CryoCase at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver (PR Newswire)
02:34AM	Loading…
May-18-24 02:34AM	Insider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... (GuruFocus.com)
May-13-24 07:08AM	Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target (MT Newswires) +5.73%
May-10-24 12:37PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript (Insider Monkey) +8.50%
May-09-24 10:57PM	BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports First Quarter 2024 Financial Results (PR Newswire)
May-02-24 10:01AM	BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-24 04:12PM	BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 (PR Newswire)
Apr-18-24 11:00AM	Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ... (GuruFocus.com)
08:05AM	BioLife Solutions Announces the Divestiture of its Stirling Freezer Business (PR Newswire)
Mar-27-24 04:37PM	Corporate Insiders Are Selling These 10 Small-Cap Stocks (Insider Monkey)
Mar-14-24 02:15AM	Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com)
Mar-13-24 01:50AM	Insider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS) (GuruFocus.com) +5.77%
Mar-04-24 08:03AM	BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences (PR Newswire)
Mar-02-24 08:16AM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript (Insider Monkey)
06:02AM	Loading…
Mar-01-24 06:02AM	Q4 2023 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents) +6.33%
Feb-29-24 04:03PM	BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-20-24 08:03AM	BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 (PR Newswire)
Jan-08-24 08:15AM	BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue (PR Newswire) +10.16%
Nov-16-23 02:54AM	BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales Cycles (Insider Monkey)
Nov-10-23 02:33PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:04PM	BioLife Solutions Reports Third Quarter 2023 Financial Results (PR Newswire)
Nov-02-23 04:03PM	BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023 (PR Newswire) +8.02%
12:27AM	Former CEO Michael Rice Sells 72,603 Shares of BioLife Solutions Inc (GuruFocus.com)
Oct-19-23 05:04PM	BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023 (PR Newswire) -8.85%
Oct-09-23 04:24AM	New Strong Sell Stocks for October 9th (Zacks)
Sep-13-23 07:47AM	New Strong Sell Stocks for September 13th (Zacks)
Aug-11-23 04:06PM	Why Shares of BioLife Solutions Plummeted This Week (Motley Fool)
06:05AM	Some BioLife Solutions, Inc. (NASDAQ:BLFS) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Aug-09-23 01:38PM	Why Shares of BioLife Solutions Are Slumping on Wednesday (Motley Fool) -28.71%
Aug-08-23 06:30PM	BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business (PR Newswire)
Jul-27-23 04:03PM	BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023 (PR Newswire)
Jul-26-23 01:30PM	Northland Capital Markets Institutional Investor Conference (ACCESSWIRE)
Jun-21-23 08:00PM	BLFS: What does Argus have to say about BLFS? (Argus Research)
Jun-14-23 08:03AM	BioLife Solutions Receives College of American Pathologists CAP-BAP Accreditation for All SciSafe® U.S. Biostorage Facilities (PR Newswire)
Jun-06-23 08:03AM	BioLife Solutions Launches the IntelliRate i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer (PR Newswire)
May-12-23 07:45AM	We Think BioLife Solutions (NASDAQ:BLFS) Can Easily Afford To Drive Business Growth (Simply Wall St.)
May-11-23 07:34AM	Q1 2023 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 05:35PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:03PM	BioLife Solutions Reports First Quarter 2023 Financial Results (PR Newswire)
May-02-23 04:03PM	BioLife Solutions to Provide First Quarter 2023 Financial Results and Business Update on May 10, 2023 (PR Newswire) -5.03%
Apr-26-23 08:00PM	BLFS: Lowering target price to $14.00 (Argus Research)
Mar-20-23 10:46PM	BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2022 Earnings Call Transcript (Insider Monkey) +6.21%
Mar-17-23 08:39AM	Q4 2022 BioLife Solutions Inc Earnings Call (Thomson Reuters StreetEvents) +7.71%
Mar-16-23 04:03PM	BioLife Solutions Reports Preliminary and Unaudited 2022 Fourth Quarter and Full Year Financial Results (PR Newswire) -6.98%
Mar-13-23 09:40AM	Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year? (Zacks) +6.51%
Mar-10-23 03:38PM	BioLife Solutions Reports Immaterial Financial Exposure to Silicon Valley Bank (PR Newswire) -13.33%
Mar-09-23 04:03PM	BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023 (PR Newswire)
Mar-01-23 08:03AM	BioLife Solutions Launches Ultraguard -70°C Phase Change Material (PCM) Accessory to Provide Backup Cooling in ULT Freezers and Dry Ice Alternative for Benchtop Biologic Material Storage (PR Newswire)
Feb-17-23 09:40AM	Is Annovis Bio (ANVS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-26-23 08:00AM	iVexSol® Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors (GlobeNewswire)
Jan-17-23 08:04AM	BioLife Solutions Announces 2023 Analyst Day & Participation in Upcoming Investor Conferences (PR Newswire) +5.99%
Jan-10-23 08:05AM	BioLife Solutions Named One of Seattle Business Magazine's Washington's Best Companies to Work For (PR Newswire)
Jan-09-23 08:05AM	BioLife Solutions Announces 2022 Fourth Quarter and Full Year Preliminary Unaudited Revenue and Introduces 2023 Revenue Guidance (PR Newswire) +9.00%
Jan-06-23 07:31AM	Is BioLife Solutions, Inc. (NASDAQ:BLFS) Potentially Undervalued? (Simply Wall St.)
Jan-03-23 06:26AM	Daily Vickers Top Buyers & Sellers for 01/03/2023 (Argus Research)
Dec-19-22 08:03AM	BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023 (PR Newswire)
Dec-18-22 04:43PM	Should You Invest in BioLife Solutions (BLFS)? (Insider Monkey)
Dec-10-22 07:12AM	Investors push BioLife Solutions (NASDAQ:BLFS) 11% lower this week, company's increasing losses might be to blame (Simply Wall St.)
Nov-21-22 08:05AM	BioLife Solutions Expands Intellectual Property Estate (PR Newswire)
Nov-17-22 08:05AM	BioLife Solutions Named in BioSpace Best Places to Work in Biopharma 2023 Report (PR Newswire) -6.31%
Nov-11-22 05:27AM	BioLife Solutions Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-09-22 06:05PM	BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -14.99% +42.77%
04:05PM	BioLife Solutions Reports Third Quarter 2022 Financial Results (PR Newswire)
Nov-03-22 08:52AM	Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 49% Undervaluation? (Simply Wall St.)
Oct-11-22 10:10AM	CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market (PR Newswire)
Oct-03-22 08:03AM	BioLife Solutions Announces COO to Retire and Join Board of Directors (PR Newswire)
Aug-25-22 08:03AM	BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors (PR Newswire)
Aug-09-22 06:35PM	BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +18.77%
04:07PM	BioLife Solutions Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Revenue Guidance (PR Newswire)
Aug-02-22 04:05PM	BioLife Solutions to Report Second Quarter 2022 Financial Results and Provide Business Update on August 9, 2022 (PR Newswire) +6.18%
Jul-18-22 06:20AM	Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load? (Simply Wall St.)
Jun-09-22 08:05AM	BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services (PR Newswire)
Jun-02-22 12:34PM	Investing in BioLife Solutions (NASDAQ:BLFS) five years ago would have delivered you a 496% gain (Simply Wall St.) +5.99%
May-09-22 05:45PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -10.80% +7.80%
04:03PM	BioLife Solutions Reports First Quarter 2022 Financial Results (PR Newswire)
May-05-22 05:15PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -6.72%
May-02-22 07:28PM	BioLife Solutions to Report First Quarter 2022 Financial Results and Provide Business Update on May 9, 2022 (PR Newswire)
07:47AM	New Strong Sell Stocks for May 2nd (Zacks)
Apr-26-22 11:18AM	3 Oversold Stocks That Could Be Ready for a Comeback (TipRanks)
Apr-07-22 04:45PM	BioLife Solutions, Inc. Announces Change of Auditor to Grant Thornton LLP (PR Newswire) -7.71%
Mar-31-22 06:44AM	New Strong Sell Stocks for March 31st (Zacks)
Mar-18-22 05:43PM	BioLife Solutions Receives Nasdaq Notice of Noncompliance for Delayed 10-K Filing (PR Newswire) +7.33% -6.66%
Mar-17-22 08:05AM	BioLife Solutions Announces Additional Delay in Filing of Annual Report on Form 10-K (PR Newswire) +6.65%

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 15 '24	Option Exercise	2.06	10,000	20,600	327,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 16 '24	Option Exercise	2.06	10,000	20,600	327,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 15 '24	Sale	23.28	10,000	232,800	317,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Oct 16 '24	Sale	23.17	10,000	231,700	317,716	Oct 17 06:25 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 18 '24	Option Exercise	2.06	10,000	20,600	327,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 19 '24	Option Exercise	2.06	10,000	20,600	327,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 19 '24	Sale	25.47	10,000	254,700	317,716	Sep 20 05:36 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 18 '24	Sale	23.90	10,000	239,000	317,716	Sep 20 05:36 PM
Foster Karen A.	Chief Quality and Operations	Sep 16 '24	Sale	25.12	267	6,707	157,568	Sep 18 05:45 PM
Foster Karen A.	Chief Quality and Operations	Jul 18 '24	Sale	22.50	240	5,400	157,931	Sep 18 05:45 PM
Foster Karen A.	Chief Quality and Operations	Aug 21 '24	Sale	25.61	96	2,459	157,835	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Sep 16 '24	Sale	25.12	367	9,219	108,158	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Jul 11 '24	Sale	20.54	287	5,895	108,607	Sep 18 05:45 PM
Berard Todd	Chief Marketing Officer	Aug 21 '24	Sale	25.61	82	2,100	108,525	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Sep 16 '24	Sale	25.12	343	8,616	317,716	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jul 11 '24	Sale	20.54	313	6,429	318,170	Sep 18 05:45 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Aug 21 '24	Sale	25.61	111	2,843	318,059	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Jul 19 '24	Sale	21.01	300	6,303	61,196	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Sep 16 '24	Sale	25.12	229	5,752	60,903	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Jul 11 '24	Sale	20.54	187	3,841	61,496	Sep 18 05:45 PM
Aebersold Sarah	Chief Human Resources Officer	Aug 21 '24	Sale	25.61	64	1,639	61,132	Sep 18 05:45 PM
Wichterman Troy	Chief Financial Officer	Jul 11 '24	Sale	20.54	828	17,007	125,141	Sep 18 05:44 PM
Wichterman Troy	Chief Financial Officer	Sep 16 '24	Sale	25.12	611	15,348	124,388	Sep 18 05:44 PM
Wichterman Troy	Chief Financial Officer	Aug 21 '24	Sale	25.61	142	3,637	124,999	Sep 18 05:44 PM
Richardson Garrie	Chief Revenue Officer	Sep 16 '24	Sale	25.12	3,070	77,118	114,773	Sep 18 05:44 PM
ABY J MATHEW	Officer	Sep 18 '24	Proposed Sale	23.45	103,404	2,424,824		Sep 18 04:37 PM
Schick Joseph	Former Director	Aug 14 '24	Proposed Sale	25.50	6,719	171,328		Aug 19 03:27 PM
Aebersold Sarah	Chief Human Resources Officer	Jul 01 '24	Sale	21.03	3,000	63,090	61,683	Jul 03 05:02 PM
Berard Todd	Chief Marketing Officer	Jun 14 '24	Sale	20.18	10,000	201,800	108,894	Jun 18 05:00 PM
Foster Karen A.	Chief Quality and Operations	May 29 '24	Sale	21.78	408	8,886	158,171	May 31 05:05 PM
Aebersold Sarah	Chief Human Resources Officer	May 29 '24	Sale	21.78	345	7,514	64,683	May 31 05:05 PM
Mathew Aby J.	EVP & Chief Scientific Officer	May 29 '24	Sale	21.78	517	11,260	318,483	May 31 05:05 PM
Wichterman Troy	Chief Financial Officer	May 29 '24	Sale	21.78	574	12,502	125,969	May 31 05:05 PM
Berard Todd	Chief Marketing Officer	May 29 '24	Sale	21.78	345	7,514	118,894	May 31 05:05 PM
Berard Todd	Chief Marketing Officer	May 17 '24	Sale	22.18	73	1,619	119,239	May 21 08:13 AM
Mathew Aby J.	EVP & Chief Scientific Officer	May 17 '24	Sale	22.18	98	2,174	319,000	May 21 08:13 AM
Wichterman Troy	Chief Financial Officer	May 17 '24	Sale	22.18	115	2,551	126,543	May 21 08:13 AM
Foster Karen A.	Chief Quality and Operations	May 17 '24	Sale	22.18	85	1,885	158,579	May 21 08:13 AM
Aebersold Sarah	Chief Human Resources Officer	May 17 '24	Sale	22.18	57	1,264	65,028	May 21 08:13 AM
Berard Todd	Chief Marketing Officer	May 15 '24	Sale	22.67	10,000	226,700	119,312	May 17 04:34 PM
Aebersold Sarah	Chief Human Resources Officer	Apr 22 '24	Sale	16.50	410	6,765	65,085	Apr 23 07:15 PM
Aebersold Sarah	Chief Human Resources Officer	Apr 18 '24	Sale	15.31	348	5,328	65,495	Apr 23 07:15 PM
Foster Karen A.	Chief Quality and Operations	Apr 18 '24	Sale	15.31	481	7,364	158,664	Apr 23 07:14 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Apr 18 '24	Sale	15.31	584	8,941	319,098	Apr 23 07:14 PM
Berard Todd	Chief Marketing Officer	Apr 18 '24	Sale	15.31	332	5,083	129,312	Apr 23 07:14 PM
Wichterman Troy	Chief Financial Officer	Apr 18 '24	Sale	15.31	956	14,636	126,658	Apr 23 07:14 PM
Berard Todd	Chief Marketing Officer	Apr 15 '24	Sale	15.67	10,000	156,700	129,644	Apr 18 08:18 AM
Aebersold Sarah	Chief Human Resources Officer	Apr 01 '24	Sale	17.65	4,000	70,600	65,843	Apr 03 05:17 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Mar 27 '24	Sale	17.99	454	8,167	319,682	Mar 29 05:40 PM
Berard Todd	Chief Marketing Officer	Mar 27 '24	Sale	17.99	515	9,265	139,644	Mar 29 05:39 PM
Foster Karen A.	Chief Quality and Operations	Mar 27 '24	Sale	17.99	395	7,106	159,145	Mar 29 05:39 PM
Wichterman Troy	Chief Financial Officer	Mar 21 '24	Sale	17.83	520	9,272	127,614	Mar 25 05:03 PM
DuRoss Amy	Director	Mar 12 '24	Sale	16.86	6,135	103,436	34,508	Mar 13 06:37 PM
DuRoss Amy	Director	Mar 13 '24	Sale	17.00	5,065	86,105	29,443	Mar 13 06:37 PM
Berard Todd	Chief Marketing Officer	Mar 12 '24	Sale	16.60	7,107	117,976	140,159	Mar 12 09:44 PM
Berard Todd	Chief Marketing Officer	Mar 11 '24	Sale	17.42	401	6,985	147,266	Mar 12 09:44 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Mar 12 '24	Sale	16.60	6,521	108,249	320,136	Mar 12 09:44 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Mar 11 '24	Sale	17.42	313	5,452	326,657	Mar 12 09:44 PM
Phillips Geraint	SVP, Global Operations	Mar 12 '24	Sale	16.60	3,598	59,727	65,998	Mar 12 09:44 PM
Phillips Geraint	SVP, Global Operations	Mar 11 '24	Sale	17.42	206	3,589	69,596	Mar 12 09:44 PM
DE GREEF RODERICK	President and CEO	Mar 12 '24	Sale	16.60	7,249	120,333	461,854	Mar 12 09:43 PM
Wichterman Troy	Chief Financial Officer	Mar 12 '24	Sale	16.60	7,249	120,333	128,134	Mar 12 09:43 PM
Wichterman Troy	Chief Financial Officer	Mar 11 '24	Sale	17.42	361	6,289	135,383	Mar 12 09:43 PM
Foster Karen A.	Chief Quality and Operations	Mar 12 '24	Sale	16.60	5,177	85,938	159,540	Mar 12 09:43 PM
Foster Karen A.	Chief Quality and Operations	Mar 11 '24	Sale	17.42	319	5,557	164,717	Mar 12 09:43 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 12 '24	Sale	16.60	4,361	72,393	69,843	Mar 12 09:42 PM
Aebersold Sarah	Chief Human Resources Officer	Mar 11 '24	Sale	17.42	269	4,686	74,204	Mar 12 09:42 PM
Aebersold Sarah	Chief Human Resources Officer	Feb 21 '24	Sale	17.35	58	1,006	41,806	Feb 23 05:52 PM
Wichterman Troy	Chief Financial Officer	Feb 21 '24	Sale	17.35	97	1,683	64,823	Feb 23 05:51 PM
Phillips Geraint	SVP, Global Operations	Feb 21 '24	Sale	17.35	131	2,273	58,120	Feb 23 05:51 PM
Berard Todd	Chief Marketing Officer	Feb 21 '24	Sale	17.35	111	1,926	115,688	Feb 23 05:51 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Feb 21 '24	Sale	17.35	101	1,752	275,214	Feb 23 05:51 PM
Foster Karen A.	Chief Quality and Operations	Feb 21 '24	Sale	17.35	87	1,509	123,940	Feb 23 05:50 PM
Aebersold Sarah	Chief Human Resources Officer	Jan 23 '24	Sale	17.11	336	5,749	41,864	Jan 25 05:10 PM
Foster Karen A.	Chief Quality and Operations	Jan 19 '24	Sale	16.76	1,198	20,078	124,027	Jan 23 05:30 PM
Phillips Geraint	SVP, Global Operations	Jan 19 '24	Sale	16.76	1,776	29,766	58,251	Jan 23 05:30 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jan 19 '24	Sale	16.76	1,450	24,302	275,315	Jan 23 05:30 PM
DE GREEF RODERICK	President and CEO	Jan 19 '24	Sale	16.76	2,642	44,280	439,897	Jan 23 05:29 PM
Wichterman Troy	Chief Financial Officer	Jan 19 '24	Sale	16.76	2,419	40,542	64,920	Jan 23 05:29 PM
Aebersold Sarah	Chief Human Resources Officer	Jan 19 '24	Sale	16.76	862	14,447	42,200	Jan 23 05:29 PM
Berard Todd	Chief Marketing Officer	Jan 19 '24	Sale	16.76	1,232	20,648	115,799	Jan 23 05:29 PM
Foster Karen A.	Chief Quality and Operations	Jan 02 '24	Sale	16.75	601	10,067	125,225	Jan 04 05:04 PM
Berard Todd	Chief Marketing Officer	Jan 02 '24	Sale	16.75	491	8,224	117,031	Jan 04 05:04 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Jan 02 '24	Sale	16.75	697	11,675	276,765	Jan 04 05:03 PM
Wichterman Troy	Chief Financial Officer	Dec 22 '23	Sale	16.79	314	5,272	67,339	Dec 28 04:46 PM
Foster Karen A.	Chief Quality Officer	Dec 01 '23	Sale	12.37	466	5,764	125,340	Dec 04 07:15 PM
Aebersold Sarah	Chief Human Resources Officer	Dec 01 '23	Sale	12.37	394	4,874	43,062	Dec 04 07:15 PM
Mathew Aby J.	EVP & Chief Scientific Officer	Dec 01 '23	Sale	12.37	591	7,311	275,961	Dec 04 07:15 PM
Phillips Geraint	SVP, Global Operations	Dec 01 '23	Sale	12.37	303	3,748	59,587	Dec 04 07:14 PM
Berard Todd	Chief Marketing Officer	Dec 01 '23	Sale	12.37	394	4,874	117,522	Dec 04 07:14 PM
Wichterman Troy	Chief Financial Officer	Dec 01 '23	Sale	12.37	666	8,238	67,112	Dec 04 07:14 PM
Foster Karen A.	Chief Quality Officer	Nov 13 '23	Sale	10.77	114	1,228	125,539	Nov 15 10:41 AM
Aebersold Sarah	Chief Human Resources Officer	Nov 13 '23	Sale	10.77	76	819	43,456	Nov 15 10:41 AM
Berard Todd	Chief Marketing Officer	Nov 13 '23	Sale	10.77	98	1,055	117,916	Nov 15 10:41 AM
Phillips Geraint	SVP, Global Operations	Nov 13 '23	Sale	10.66	111	1,183	59,656	Nov 15 10:41 AM
Mathew Aby J.	EVP & Chief Scientific Officer	Nov 13 '23	Sale	10.77	132	1,422	275,726	Nov 15 10:41 AM
Wichterman Troy	Chief Financial Officer	Nov 13 '23	Sale	10.66	97	1,034	67,480	Nov 15 10:40 AM
Rice Michael	Former CEO and Director	Oct 30 '23	Sale	9.13	72,603	662,865	347,085	Nov 01 05:30 PM

LAB

Standard BioTools Inc

BLFS

Biolife Solutions Inc

Upgrade your FINVIZ experience